NEW YORK (GenomeWeb News) – Vermillion today reported a 35 percent improvement for its second-quarter net loss but no revenues for the three months ended June 30, 2008.
 
The company’s net loss shrank to $4.5 million, or $.70 per share, from $6.8 million, or $1.74 per share, in the second quarter of 2007.
 
Earnings-per-share calculations for both years account for the 10-for-one reverse stock split that the company enacted in March.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.